Schedule 13G ownership disclosure

Keros Therapeutics Inc

Common Stock, $0.0001 par value per share (the "Common Stock") · CUSIP: 492327101

Event date: 2025-05-07

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Madison Avenue Partners, LP

    Shares: 2,614,402 · Class: 6.4%

  • Madison Avenue International LP

    Shares: 2,614,402 · Class: 6.4%

  • EMAI Management, LLC

    Shares: 2,614,402 · Class: 6.4%

  • Madison Avenue GP, LLC

    Shares: 2,614,402 · Class: 6.4%

  • Caraway Jackson Investments LLC

    Shares: 2,614,402 · Class: 6.4%

  • Eli Samaha

    Shares: 2,614,402 · Class: 6.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001013594-25-000650
Form type
SCHEDULE 13G
Filer
Keros Therapeutics, Inc.
CIK
CIK 1664710
Filed
May 14, 2025
Reporting period
May 07, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub